Objective: To examine the exact profile of expression and to determine the functional significance of the angiotensin II (Ang II), type 1 (AT ) and type 2 (AT ) receptors during rat aortic development and following rat carotid artery balloon injury. Methods: AT and AT 1 2 1 2 mRNA levels in rat aortae were measured using a quantitative reverse transcription polymerase chain reaction technique. Ang II receptor function was assessed by quantitating the effects of AT (DuP753) and AT (PD123319) receptor antagonists during these processes. 
Introduction
receptor demonstrated that it too belongs to the same seven transmembrane superfamily [8] [9] [10] . However, the AT and 1 Until recently, it was believed that angiotensin II (Ang AT subtypes are only 34% identical in sequence. As 2 II) exerts most of its actions via the G-protein-coupled shown by binding assays, the AT receptor is highly 2 type 1 (AT ) receptors, which either activate phospholipexpressed in embryonic tissue, including the vasculature, 1 ase C or inhibit adenylate cyclase. This receptor belongs to but is expressed at low levels (if at all) in the adult, where the superfamily of seven transmembrane domain receptors the AT receptor subtype predominates [8] [9] [10] [11] [12] .
1 [1] [2] [3] [4] [5] . A second receptor subtype, the AT receptor, was In vitro and in vivo studies confirm that Ang II plays an 2 initially defined by its selective binding to ligands important role in the growth of vascular smooth muscle PD123319 and CGP42112 [6, 7] . Molecular cloning of this cells [13] [14] [15] [16] [17] [18] . Because the AT receptor subtype predomi-1 nates in adult vasculature, the growth effects of Ang II were hypothesized to be mediated via the AT receptor. In 1 Ang II in adult smooth muscle cells can be blunted by lesion. However, there are serious caveats to this observaantagonists specific for the AT receptor [17, 18] . Moretion. Because the compound was delivered periadventitial-1 over, Powell et al. [16] and others [14, [17] [18] [19] reported that ly, the local concentration of the compound in the injured angiotensin converting enzyme (ACE) inhibitors can prevessel could not be assessed and may be quite high. vent neointimal formation following balloon injury in rats.
Therefore, a nonspecific biochemical effect of CGP42112 This effect of ACE inhibitors on neointimal formation is or a crossover effect of this AT ligand to the AT 2 1 due, in part, to blockade of Ang II production, as evireceptors cannot be ruled out, especially in light of the denced by the ability of the angiotensin receptor antagoassumption that the AT receptor is the predominant 1 nist, DuP753, to prevent neointimal hyperplasia [17] . receptor subtype expressed in the adult. However, evidence suggests that the increase in kinins
To better understand the potential function of the Ang II observed with ACE inhibitors may also play a role [18] .
receptors during fetal growth, as well as growth following Several components of the renin angiotensin system are vascular injury, we have established a competitive, quanhighly expressed during embryonic development. In addititative reverse transcription polymerase chain reaction tion to AT and AT receptor expression in the developing (PCR) assay to measure the mRNA encoding these re-1 2 rat, ACE, renin and high levels of Ang II have been ceptors. Using this assay, we examined the expression observed [11, 12, [20] [21] [22] . Functional studies of the role of pattern of the Ang II receptor during normal pre-and these components are few; however, reports suggest that postnatal aortic development, and in the carotid artery they may play a role in pulmonary vessel muscularization following injury. Ang II receptor function was then as well as nephrovascular development [20, 21] . During assessed during these processes by quantitating the effects prenatal growth, several processes that may be modulated of the AT receptor antagonist, DuP753, and the AT 1 2
by Ang II are necessary for appropriate development of the receptor antagonist, PD123319, on vascular DNA synvessel wall. Following angiogenesis, migration and difthesis. ferentiation of mesenchymal cells occurs to form the immature vessel. During later embryonic and fetal stages, rapid proliferation of smooth muscle is initially observed, 2. Methods followed by a developmentally regulated decrease in growth. Also observed during fetal and neonatal develop-
The investigation conforms with the Guide for the Care ment is the differentiation and maturation of vascular receptor in regulation of adult vascular smooth muscle described previously [14, 23] The right uninjured carotid cannot be discounted. For example, neointimal smooth artery served as a control. Tissues were harvested at muscle cells are phenotypically distinct from the medial indicated times after injury. During the harvesting prosmooth muscle, as evidenced by the expression in the cedure, the adventitia was physically removed from both neointimal cells of a subset of the proteins normally the injured and non-injured control vessel. In this model, expressed in embryonic or neonatal smooth muscle cells.
the vessel does not become re-endothelialized. Therefore, These include the re-expression of neonatal isoforms of to better compare the characteristics of the smooth muscle certain cytoskeletal and extracellular matrix proteins, as in the vessels, the endothelial cells were removed from the well as expression of certain growth factors and growth control vessel by water perfusion. factor receptors [9, [24] [25] [26] [27] [28] , raising the possibility that the AT receptor may be re-expressed following injury. Inter-2.3. RNA isolation 2 estingly, Janiak et al. [29] reported that in vivo administration of CGP42112, a specific AT receptor ligand, atTotal RNA was isolated from embryonic [days 14 to 17 2 tenuates development of the neointimal lesion in rats. This (E14 to E17)], fetal (E18 to E21), postnatal (days 1 to 4, 7, observation supports the possibility that the AT receptor 8, 12), and adult (12 weeks) rat aortae, and control and 2 ® may play a role in the development of the neointimal injured carotid arteries using RNAzol B (Friendswood, TX, USA). For RNA isolation from injured and control reverse primer AT (V) give a 555-bp product. The spe-2 carotid arteries, typically 10-20 vessels were pooled. For cificity of the 555 bp AT cDNA fragment was assessed 2 RNA isolation from developing aorta, typically 10-20 by digestion with Ava II, which resulted in expected vessels were pooled. Total RNA was subsequently treated products of 199 and 356 bp (Data not shown). with RNase-free DNase 1 (Gibco BRL, Gaithersburg, MD, As controls, glyceraldehyde-3-phosphate dehydrogenase USA) to remove any contaminating genomic DNA that (G3PDH) was used to compare carotid injury RNA may have been found in the sample. One unit of DNase samples, and a-tubulin was used to compare developmenwas added per mg of RNA in 20 mM Tris-HCl, 50 mM tal samples. The G3PDH primers were taken from the rat KCl and 2.5 mM MgCl and incubated at room temperasequence forward primer, 59 AAGCTAACTGAGATCAT-2 ture for 15 min. The reaction was terminated with the CAACA 39, and reverse primer, addition of 1 ml of 20 mM EDTA (pH 8.0) and incubation 59ATGCGAAAGTTGGGTGTCTGCA 39 [31] . a-Tubulin at 658C for 10 min. The solution was re-extracted with primers were also obtained from a rat sequence [32] :
In preliminary studies, this procedure had no forward primer, 59 TCAAGGTTGGCATCAACTACC 39, effect on the PCR product generation from RNA but and reverse primer, 59 TTTGACATGATACAGGGACTG abolished the generation of product from genomic DNA 39. The G3PDH primers yielded a 418-bp product and (data not shown).
a-tubulin primers a 336-bp product. Both primer sets spanned an intron.
Polymerase chain reaction
Total RNA (0.2 to .1 mg) was reverse transcribed using 2.5 mM random hexamers and 50 U of MMLV AT -specific primers were chosen so that both AT and reverse transcriptase (Perkin Elmer Cetus, Norwalk, CT, 39, which are located in the third and fifth transmembrane The PCR products are resolved by gel electrophoresis, and domains, respectively (positions 527 to 544 and 826 to the point at which the signal from the endogenous mRNA 843). The forward primer and reverse primer AT (III) give equals that of the exogenously added RNA is defined 2 a product of 256 bp, whereas the forward primer and visually. At this point, the two RNAs are present in equal concentrations, thus allowing quantitation of the endogenexpected length (571 bp) was obtained following electroous sequence.
phoresis on a 1.5% agarose gel. This product was diluted Quantitative RT-PCR was performed using a competi-1:100 in water and 2 ml were re-amplified using the tive recombinant (rc)RNA internal standard that was conditions stated above. PCR products from several ampli-TM synthesized using a modification of the method of Heuvel fications were pooled and purified using the Magic Prep et al. [34] (see Fig. 1 performed on AT cDNA in a reaction mixture consisting analysis, the sample RNA and increasing amounts of the 1 of 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2 mM MgCl , rcRNA internal standard were mixed together before 2 0.6 mM forward and reverse rcRNA primers and 1 ng of addition to the reverse transcriptase reaction mixture. AT cDNA. Taq DNA polymerase (2.5 U) was added A similar procedure was used to synthesize the AT 1 2 during a hot start. PCR was performed at 948C for 1 min, RNA standard, which used the AT (I) forward primer and 2 568C for 2 min and at 728C for 2 min for 35 cycles AT (III) and AT (V) reverse primers. the rcRNA internal standard, serial dilutions of neonatal tinued until sacrifice. BrdU was injected at 18 h (100 RNA samples were made and tested against the rcRNA mg / kg subcutaneously and 30 mg / kg intraperitoneal) and standard. In each case, shifts in the crossover point were at 12 h (30 mg / kg intraperitoneal) before sacrifice. Folobserved, consistent with the dilutions in the target RNA.
lowing sacrifice, the samples were processed as described As a second method to standardize our technique, a target above. sequence was constructed in a fashion similar to that used to create the rcRNA internal standard. The forward rcRNA primer was used along with a second primer that was 3. Results constructed by linking the distal primer [i.e., primer AT (VI) for AT ] to a poly(T) tail. After PCR and
Although it has been reported that the AT receptor is 1 1 2 transcription, an RNA target is generated that can be prenatally expressed in the vasculature, little is known quantitated and that amplifies to the size of the native concerning the profiles of expression (i.e., when expression messenger RNA. Competitive RT-PCR assays using the commences, when expression is at its highest, and when synthesized target against the internal standard revealed expression decreases Assessments of DNA synthesis in developing aortae Fig. 2A -B. Total RNA (0.2 mg) isolated from aortae were made by quantitating incorporation of bromodeoxremoved at various times from E14 to 12 weeks postyuridine (BrdU, Sigma, St. Louis, MO, USA) into aortae partum (adult) was reversed transcribed; the resultant similar to a procedure described by Cook et al. [35] .
cDNA was amplified by PCR. The 623 bp RT-PCR Briefly, pregnant female Sprague-Dawley rats at various product of the amplification of the AT receptor mRNA 1 gestational days were injected with 100 mg / kg body was easily detected in the amplification product of RNA weight BrdU at 18, 12 and 1 h before sacrifice. Following isolated from aortae removed from E14 rats. Because of sacrifice, whole embryo or dissected aortae were placed in the small size of the aorta, it was difficult to examine the 4% paraformaldehyde for 12 h. Samples were subsequentvascular expression of the AT receptor at earlier times.
1 ly paraffin embedded, sectioned and stained for BrdU However, the amplification product of the AT receptor 1 using a kit purchased from Zymed Laboratories (South San mRNA could be seen in RNA isolated from whole embryo Francisco, CA, USA). BrdU incorporation was measured at E9. Interestingly, the levels of expression of the AT 1 as a percentage of BrdU immunoreactive nuclei / total receptor mRNA remained relatively constant (with minor nuclei present within the medial smooth muscle cell layer.
fluctuations) throughout pre-and postnatal development. In Differentiation of the medial smooth muscle cell layer mouse and rat, two isoforms of the AT receptor have been Keiser, Parke Davis), were infused into pregnant rats. Rats that seen with total AT mRNA, whereas levels of the 1 were anesthetized using NO and halothane gas under AT mRNA appeared unchanged throughout develop1b carefully controlled conditions. Alzet pumps (Alza, Palo ment. Alto, CA, USA) were then placed subcutaneously to
We next examined the expression of the AT receptor Potential teratogenic effects were assessed by comparing PCR products derived from AT mRNA were not abun-2 litters with regard to size, malformations, crown-rump dant until E17. From E17, levels increased to a maximum length and body weight. No significant differences in these at postnatal day one and rapidly decreased thereafter. parameters were observed.
Several controls were run to demonstrate the validity of Functional analysis of AT and AT receptor pathways the RT-PCR results. To control for input mRNA, co-1 2 following carotid injury were made in a similar fashion. amplification of an internal housekeeping gene product is Receptor antagonists were infused (20 mg / kg / day) subusually performed. However, during embryonic and fetal cutaneously for four days before carotid injury and condevelopment, the phenotype of the cells changes dramati- and maintained at relatively similar levels. Conversely, AT levels were detected between E15 and E16 and increased to a maximum at postnatal day 1. expression throughout postnatal development [33] . Coneffects that the specific antagonists, DuP753 and sistent with this, the yield of PCR product obtained with PD123319, had on DNA synthesis in the aorta (Fig. 3) . the a-tubulin primers (336 bp product) was similar at the Drugs were administered maternally using Alzet time points examined. minipumps for four days before tissue harvest. On the last Since the genes encoding the AT and AT receptors do day, BrdU was administered maternally by intraperitoneal 1 2 not contain introns within the coding region and, therefore, injection. As shown previously by Cook et al. [35] , a the above PCR primers would not distinguish cDNA from developmentally regulated decrease in DNA synthesis was genomic DNA. Therefore, all RNA samples were treated observed. During early gestation (E15), 73% of the aortic with RNase-free DNase before amplification. As an added nuclei displayed positive immunoreactivity for BrdU foltest to ensure that the products generated were a result of lowing an 18-h exposure to the compound, demonstrating amplification of cDNA and not due to amplification of the rapid growth of the embryonic aorta. This rate dropped genomic DNA, RNA samples were digested with DNaseprogressively such that, on E21, the rate of DNA synthesis free RNase A. When RNase was added before first strand was 37%. As we showed previously [23] , this developmencDNA synthesis, no product was observed following the tally regulated decrease in DNA synthesis is mediated, in PCR. However, when the RNase was added after first part, by the action of the AT receptor. At days E18, E19 2 strand cDNA synthesis, the yield of product was unaffectand E21, administration of the AT receptor antagonist 2 ed (data not shown). increased DNA synthesis towards the maximum rate Using competitive RT-PCR, the levels of AT and AT observed on day E15. In contrast, infusion of the AT 1 2 1 receptor mRNA were quantitated in developing aortae. receptor antagonist had opposing effects on DNA synInternally deleted RNA standards, consisting of truncated thesis. A significant decrease in BrdU incorporation was AT and AT sequences, were generated as shown in and AT -specific primers yielded products of 534 and 275 2 bp, respectively. When the standard RNA was added to aortic RNA at appropriate levels, competition resulted (for example, see Fig. 2 ). The efficiency of the competition reactions was assessed as described in Section 2. In contrast to previous reports [11, 12] that suggest that the AT receptor predominates during fetal aortic develop-2 ment, we found that, at early gestation (E15), AT and 1 AT receptor mRNA levels were similar (Fig. 2C) growth, the balloon injured rat carotid artery (Fig. 4 Because activated medial smooth muscle cells and neointi- from the injured carotid artery with DNase-free RNase A before first strand cDNA synthesis completely abolished the PCR signal (Fig. 4C) . between days three and four, when AT receptor levels 2 We have previously shown that overexpression of the were dropping to 2% of the total population and AT 1 AT receptor by the use of in vivo gene transfer, resulting receptor levels were increasing by 2.5-fold over control 2 in AT mRNA levels that were 20-fold greater than that values. Again, AT receptor antagonism decreased BrdU 2 1 observed for the endogenous receptor (i.e., at levels labeling indices, in this case, to 50% of that of the comparable to the AT receptor mRNA) could inhibit nontreated, injured controls. However, during this interval, 1 DNA synthesis in the balloon injured vessel [23] . How-AT receptor blockade had no effect on the BrdU labeling 2 ever, the biological effects of the much lower levels of index or inhibition due to AT receptor blockade.
1 expression of the endogenous receptor are unknown. Therefore, the functional significance of these changes in angiotensin receptor expression was again assessed using BrdU incorporation studies (Fig. 5) . The angiotensin 4. Discussion receptor antagonists were administered by Alzet minipumps continuously from four days before injury until Recent reports suggest that the Ang II receptors, AT 1 two days after injury. On the last day, BrdU was adminisand AT , mediate opposing effects on growth [23, 37] , with 2 tered to measure the rates of DNA synthesis. This time AT pathways promoting growth and AT pathways 1 2 interval was chosen because, during this time, the AT inhibiting growth. However, the majority of the studies 2 receptor levels increased to 10% of the total Ang II have concentrated on cell culture observations. In the receptor population, while the AT receptor levels represent study, we extend these observations by showing 1 mained at control levels. Consistent with the results of that the angiotensin receptors play an important role in Prescott et al. [17] , AT receptor antagonist reduced BrdU vivo in regulating developmental maturation of blood 1 labeling indices to 35% of that of the nontreated injured vessels and vascular response to injury. During both of vessel. Similar to results seen in the prenatal aorta, the AT these processes, AT and AT receptors have reciprocal and AT receptor pathways appeared to mediate opposing effects on growth.
2 functions. AT receptor antagonism increased synthesis To assess AT expression during development and after 2 2 (7.960.4 versus 12.260.8, P,0.01) during this time carotid injury, we used a competitive RT-PCR technique, interval. Simultaneous infusion of both antagonists again employing an exogenous RNA template as an internal increased DNA synthesis compared to DuP753 treatment competitor. Because both the target mRNA and the levels (2.860.3 versus 7.660.5, P,0.01), again suggestinternal standard compete for the same primer sequences, ing that the antiproliferative effects of the AT receptor amplification is truly competitive. Several methods exist to 1 blockade may be due, in part, to the unopposed action of synthesize competitive RNA standards, ranging from clasAng II at the AT receptor.
sical DNA engineering to PCR-based methods. Our tech-
2
We next examined the effect of receptor blockade nique, as outlined in Fig. 1 , is a simplified version of that proposed by Heuvel et al. [34] . The technique is simple, influence the rates of vascular growth during these time rapid and can be completed in a few days. The technique periods. differs from that of Heuvel et al. [34] in that the target One may argue that the effects of the angiotensin mRNA and exogenous competitor RNA are identical, receptor antagonists during development are a result of except for the deletion. Therefore, the efficiencies for RT effects on placental blood flow. Although placental flow and PCR steps should be essentially identical between could have been altered, several lines of evidence suggest target and competitor RNAs. Competitive RT-PCR is a that differences in the rates of vascular growth were not sensitive technique that can discern differences in mRNA due to alterations in flow. First, no differences were levels as little as two-fold or less. The sensitivity could be observed between treated and control groups with regard to increased further by narrowing the concentration range and the gross parameters of growth (crown-rump length, fetal 32 using P or radiolabeled primer in the PCR reaction. AT expression remains at levels similar to those found on [40] and AT [41] A potential role for the renin-angiotensin system during out mouse does not show vascular abnormalities under development is suggested by previous studies [23, 37] . Our basal conditions [43] . One reason for the lack of vascular laboratory has previously shown that ACE is found in high abnormalities in the AT knockout animal (and the lack of 2 concentrations in the vascular media during development more widespread abnormalities in the ACE, angioten- [23] . Moreover, Jones et al. [22] found that circulating Ang sinogen and AT /AT animals) may be the redundancy 1a 1b
II levels are much higher in the fetus than in the adult rat. and compensatory regulation of the systems responsible for Using BrdU incorporation as a measure of DNA synthesis, controlling growth and development. For example, pharwe found that the AT and AT receptors mediate opposmacologic blockade of the AT receptor during develop-1 2 2 ing growth-related functions. AT pathways are growthment (Fig. 3) did not result in the long-term prolongation 1 promoting, whereas AT pathways are growth-inhibitory. of the high rates of growth seen at day E15. What was 2 Infusion of DuP753 decreased BrdU incorporation on E18, observed was a rightward shift in the decrease by one-two E19 and E21, while PD123319 infusion increased incorpodays. Similarly, pharmacologic blockade of the AT re-1 ration on each of these days [23] . Of note, the rates of ceptor did not immediately shut off DNA synthesis, but DNA synthesis in the aortas of fetal mice receiving both shifted the decrease leftward, again by one-two days. DuP753 and PD123319 increased incorporation to levels These results suggest that there are probably multiple that were indistinguishable from those observed with regulatory pathways involved in the regulation of vascular infusion of PD123319 alone, suggesting that some of the development. Similarly, the knockout mice must have growth inhibitory effects of AT receptor antagonists may other pathways to compensate for the loss of the AT or work by Janiak et al. [29] , which showed that the observations is unknown but may be related to the the injured vessel in our study provides important con- 
